Skip to main content

Peer Review reports

From: Evaluation of ITGB1 expression as a predictor of the therapeutic effects of immune checkpoint inhibitors in gastric cancer

Original Submission
19 Nov 2022 Submitted Original manuscript
26 Jan 2023 Reviewed Reviewer Report
22 Mar 2023 Reviewed Reviewer Report
17 Apr 2023 Reviewed Reviewer Report
6 Jun 2023 Author responded Author comments - Hui-Qing Jiang
Resubmission - Version 2
6 Jun 2023 Submitted Manuscript version 2
11 Jun 2023 Author responded Author comments - Hui-Qing Jiang
Resubmission - Version 3
11 Jun 2023 Submitted Manuscript version 3
19 Jun 2023 Author responded Author comments - Hui-Qing Jiang
Resubmission - Version 4
19 Jun 2023 Submitted Manuscript version 4
25 Jun 2023 Author responded Author comments - Hui-Qing Jiang
Resubmission - Version 5
25 Jun 2023 Submitted Manuscript version 5
29 Jun 2023 Author responded Author comments - Hui-Qing Jiang
Resubmission - Version 6
29 Jun 2023 Submitted Manuscript version 6
2 Jul 2023 Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
22 Aug 2023 Editorially accepted
4 Sep 2023 Article published 10.1186/s12876-023-02930-0

You can find further information about peer review here.

Back to article page